NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science
In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General
“Our Job Is to Be The One Agency That Speaks To Cancer”
“The One Thing You Want From AN NCI Director: He Will Be Bound By The Facts”
NCABP “Anyone With Same Facts Would Have Come To Same Conclusion
Prevention Trial Could Stand On Its Own
Chabner : Opportunity To Set Own Agenda Reason For Leaving
Trending Stories
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- U.S. News & World Report expands evaluation of outcomes in cancer subspecialties
- GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise - FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies? - Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya